MediWound Ltd.

Contributing Author

Recent Articles by MediWound Ltd.

Dec-10	MediWound Reports New Clinical Data Demonstrating NexoBrid's Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries MDWD GlobeNewswire
Nov-20	MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update MDWD GlobeNewswire
Nov-05	MediWound to Report Third Quarter 2025 Financial Results MDWD GlobeNewswire
Nov-03	MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid MDWD GlobeNewswire
Sep-29	MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares MDWD GlobeNewswire
Sep-25	MediWound Expands Global Reach with Marketing Approval of NexoBrid in Australia MDWD GlobeNewswire
Sep-02	MediWound's NexoBrid to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress MDWD GlobeNewswire
Aug-20	MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference MDWD GlobeNewswire
Aug-14	MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update MDWD GlobeNewswire
Aug-13	MediWound Announces New EscharEx Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers MDWD GlobeNewswire
Aug-04	MediWound to Report Second Quarter 2025 Financial Results MDWD GlobeNewswire
May-21	MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update MDWD GlobeNewswire
May-13	MediWound Announces Publication of Phase II EscharEx Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers MDWD GlobeNewswire
May-05	MediWound to Report First Quarter 2025 Financial Results MDWD GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.